Emerging approaches in preventing cardiovascular disease
Key result
Emerging preventive therapies, including antioxidants and homocysteine lowering, have not yet been proven in clinical trials to reduce cardiovascular morbidity and mortality.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Prioritize established risk factor control; leaves open whether future trials will support antioxidants or homocysteine lowering.
Structured PICO
I
Intervention
Emerging preventive therapies including antioxidants, homocysteine lowering, ACE inhibitors, antibiotics, and anti-inflammatory agents
While new preventive therapies are being studied, current emphasis should remain on treating established cardiovascular risk factors.
Cite This Study
Lonn et al. (1999) conducted a review in Cardiovascular disease. Emerging preventive therapies was evaluated. Emerging preventive therapies, including antioxidants and homocysteine lowering, have not yet been proven in clinical trials to reduce cardiovascular morbidity and mortality.